Tag Archives: san

Liberty Tax Service DocuSigns to Delight Customers With Faster Return Processing

Posted on by

SAN FRANCISCO–(BUSINESS WIRE)– DocuSign, The Global Standard for eSignature, announced that Liberty Tax Service, whose parent company is JTH Holding, Inc. (TAX), is using DocuSign to create a better customer experience by providing faster tax return processing for customers. DocuSign has helped Liberty Tax Service cut the time customers spend signing required bank and tax documents by 50 percent so customers get their returns filed quicker Continue reading →

Trans-Pacific Aerospace Company Receives SAE AS81820, SAE AS81934 Certification; Becomes Only Qualified Manufacturer …

Posted on by

SAN MARINO, Calif.–(BUSINESS WIRE)– Trans-Pacific Aerospace Company, Inc. (TPAC) announced today that its China subsidiary has passed all qualification testing for SAE Aerospace Standard 81820 and has received formal written qualification approval from the U.S. Continue reading →

Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of …

Posted on by

SAN DIEGO, Feb. 13, 2013 /PRNewswire/ –Shire plc (LSE: SHP, NASDAQ: SHPG), the company’s Regenerative Medicine business, its community education program HealTogether, and celebrity chef Charles Mattocks announced today the launch of “The Diabetic You” Mobile Tour. Continue reading →

Freedom Meditech Receives FDA 510(k) Clearance for ClearPath DS-120™

Posted on by

SAN DIEGO–(BUSINESS WIRE)– Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell its first product, the ClearPath DS-120 Lens Fluorescence Biomicroscope. The ClearPath is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light Continue reading →

Jennerex Announces Nature Medicine Publication Highlighting Randomized Overall Survival Benefit of Lead Product …

Posted on by

SAN FRANCISCO, CA–(Marketwire – Feb 10, 2013) – Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of research demonstrating the ability of its lead product-candidate, Pexa-Vec (JX-594) to significantly prolong survival in advanced hepatocellular carcinoma (HCC) patients in a randomized dose comparison clinical trial. Continue reading →

Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa

Posted on by

SAN DIEGO, February 8, 2013 /PRNewswire/ — Shire plc (LSE: SHP, NASDAQ: SHPG), today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US. [i] “People affected by EB suffer skin blisters and almost constant, acute pain and scarring,” said the study’s Principal Investigator, H. Alan Arbuckle, MD, Section Head Pediatric Dermatology Kaiser Permanente Colorado, Wound Care Consultant, Epidermolysis Bullosa Center of Excellence, The Children’s Hospital, Aurora Colorado Continue reading →

Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum

Posted on by

SAN DIEGO, Jan. 29, 2013 /PRNewswire/ –Cardium Therapeutics (NYSE MKT: CXM) today announced a presentation at the 2013 Phacilitate Annual Cell & Gene Therapy Forum in Washington, DC. The Company’s presentation, “Optimizing Phase III Trial Design for Generx (Ad5FGF-4)” by Cardium’s Chief Scientific Officer, Gabor M. Continue reading →

NASA and Autodesk Collaborate on Sustainable Building Performance Monitoring

Posted on by

SAN FRANCISCO–(BUSINESS WIRE)– Autodesk Inc., (ADSK) and NASA Ames Research Center are collaborating to research and develop new technology that can monitor and optimize the operational life-cycle of high performance buildings. Researchers from Autodesk Research and NASA will implement Autodesk Project Dasher technology at the NASA Ames Sustainability Base, a 50,000 square foot office building and showcase for technologies enhancing efficient resource utilization, including those developed by NASA for its space and aeronautics missions. Continue reading →

NASA to Launch New Mars Rover in 2020

Posted on by

SAN FRANCISCO NASA will launch a new Mars rover in 2020, agency officials announced today (Dec. 4). The unmanned rover’s chassis and landing system will be based heavily on NASA’s $2.5 billion Curiosity rover, which has been tooling around the Red Planet since August of this year, said John Grunsfeld, NASA’s associate administrator for science. Continue reading →

Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire …

Posted on by

SAN DIEGO, CA–(Marketwire – Dec 4, 2012) – Invivoscribe Technologies, Inc., a privately-held life science company based in San Diego, California, announces the launch of Genection, Inc. Genection provides physicians with a dedicated online platform for global access to the entire clinically-actionable genetic test menu, including both routine and esoteric genetic tests, exome and whole genome sequencing, cancer somatic mutation testing, and pharmacogenomics. Genection’s model is not payor driven, so prescribing physicians have access to genetic tests that may currently be unavailable, overlooked, or even inaccessible through their patients’ managed care plans and health care institutions Continue reading →

Freedom of Information is not just about media

Posted on by

Kuwento By Benjamin Pimentel SAN FRANCISCO President Benigno Aquino III has said he supports the Freedom of Information bill, which just took a small step forward this week with the approval of the House committee on public information. But its clear that Aquino also has reservations about the FOI bill, and these concerns appear to be based on a misconception: He thinks Freedom of Information is all about media. This was evident in some of his remarks focused on how FOI could help journalists. Continue reading →